Table 4 Major adverse cardiac events, mortality and bleeding events at 30 days in the protocol (n = 99) and non-protocol (n = 291) treated groups
Protocol | Non-protocol | p-value | |
|---|---|---|---|
n (%) | n (%) | ||
MACE | 6 (6.1) | 31 (10.7) | 0.178 |
Cardiovascular death | 4 (4.0) | 26 (8.9) | 0.114 |
Non-fatal myocardial infarction | 0 (0) | 1 (0.3) | 0.559 |
Non-fatal stroke | 1 (1.0) | 4 (1.4) | 0.781 |
Target vessel revascularisation | 1 (1.0) | 3 (1.0) | 0.986 |
Death from any cause | 5 (5.1) | 28 (9.6) | 0.158 |
Severe GUSTO bleeding | 0 (0) | 3 (1.0) | 0.311 |
Mild or minor GUSTO bleeding | 3 (3.0) | 6 (2.1) | 0.579 |
Major TIMI bleeding | 0 (0) | 1 (0.3) | 0.559 |
Minor or minimal TIMI bleeding | 2 (2.0) | 4 (1.4) | 0.652 |